📰 Consensus News
Page 926 - Consensus News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Consensus. Real-time updates on events, politics, business and more.
February 28, 2024
Shares of ProFrac Holding Corp. (NASDAQ:ACDC – Get Free Report) have been given a consensus rating of “Moderate Buy” by the four ratings firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The […]
February 28, 2024
Shares of Stanley Black & Decker, Inc. (NYSE:SWK – Get Free Report) have been given an average recommendation of “Hold” by the eleven ratings firms that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and four have assigned a […]
February 28, 2024
Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ten analysts that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price […]
February 28, 2024
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy […]
February 28, 2024
UniFirst Co. (NYSE:UNF – Get Free Report) has been given an average recommendation of “Reduce” by the four research firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating and three have issued a hold rating on the company. The average 1-year price target […]
February 28, 2024
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the four brokerages that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month […]
February 28, 2024
Shares of Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year […]
February 28, 2024
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among […]
February 28, 2024
Shares of UWM Holdings Co. (NYSE:UWMC – Get Free Report) have been given an average recommendation of “Reduce” by the eleven ratings firms that are presently covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating on […]
February 28, 2024
UWM Holdings Co. (NYSE:UWMC – Get Free Report) has been given a consensus rating of “Reduce” by the eleven analysts that are covering the stock, Marketbeat reports. Four research analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and two have issued a buy recommendation on the company. The […]